Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jul;162(1):202-210.
doi: 10.1002/ijgo.14634. Epub 2023 Jan 20.

Treatment for mild hypertension in pregnancy with different strategies: A systematic review and meta-analysis

Affiliations
Meta-Analysis

Treatment for mild hypertension in pregnancy with different strategies: A systematic review and meta-analysis

Zhichao Chen et al. Int J Gynaecol Obstet. 2023 Jul.

Abstract

Objectives: To synthesize the evidence from randomized controlled trials (RCTs) of antihypertensive treatment for mild pregnancy hypertension.

Methods: We searched various databases from inception to June 2022, using keywords including hypertension; pregnancy; therapy; treatment; pregnancy outcomes; maternal outcomes; and perinatal outcomes. Only RCTs of antihypertensive treatment for mild hypertension in pregnancy comparing placebo/no therapy were included. We used Review Manager version 5.3 for statistical analyses.

Results: In all, eight studies were eligible, with a total of 4211 participants. Compared with control, the active treatment significantly prevented preeclampsia (OR 0.55; 95%CI, 0.39-0.78), placental abruption (OR 0.39; 95%CI, 0.17-0.91), severe hypertension (OR 0.35; 95%CI, 0.17-0.71), end-organ dysfunction (OR 0.34; 95%CI, 0.19-0.62) and preterm birth (OR 0.69; 95%CI, 0.59-0.82), with no increased risk of small for gestational age (SGA) (OR 1.25; 95%CI, 0.78-2.00), or admission to the NICU (OR 0.83; 95%CI, 0.54-1.28). Subgroup analyses demonstrated that the tight control group did not show an advantage over the less-tight control group in improving pregnancy outcomes.

Conclusion: In pregnant women with mild pregnancy-induced hypertension or chronic hypertension, antihypertensive treatment still provided precise benefits of improving pregnancy outcomes without increased risk in fetal outcomes.

Keywords: antihypertensive agents; hypertension; meta-analysis; pregnancy; pregnancy outcome; systematic review.

PubMed Disclaimer

References

REFERENCES

    1. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy. American College of Obstetricians and Gynecologists., Task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122-1131.
    1. ACOG practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133:1.
    1. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin no. 203: chronic hypertension in pregnancy. Obstet Gynecol. 2019;133(1):e26-e50.
    1. Chappell LC, Cluver CA, Kingdom J, Tong S. Pre-eclampsia. Lancet. 2021;398:341-354.
    1. Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a who systematic analysis. Lancet Global Health. 2014;2(6):e323-e333.

Substances

LinkOut - more resources